Elsevier

American Heart Journal

Volume 203, September 2018, Pages 109-117
American Heart Journal

Research Letters
Comparison of 2 ambulatory patch ECG monitors: The benefit of the P-wave and signal clarity

https://doi.org/10.1016/j.ahj.2018.03.022Get rights and content

Section snippets

Methods

This study compared 2 FDA-approved monitors: the ZioPatch Monitor, Zio-XT (iRhythm Technologies, Inc, San Francisco, CA) and the Carnation Ambulatory Monitoring, CAM (BDx, Inc, Seattle, WA) (Figure 1).

The primary outcomes of this prospective comparative study were to compare the ECG signal clarity and to determine whether there were differences in rhythm types diagnosed between the 2 monitors. Secondary end points were whether variances in the findings on the CAM or Zio-XT resulted in

Patient demographics

Thirty consecutive patients consented to the study. Patient age was 73.1 ± 7.1 years (range 52–87), with 20 men and 10 women. One patient was found to have no data recorded on the Zio-XT upon analysis by the Zio-XT reading center, and therefore, comparative ECG analysis was available for 29 of 30 patients.

Arrhythmia inventory

A total of 86.7 ± 0.6 arrhythmias were inventoried from the Zio-XT AEM set and 121.7 ± 2.1 from the CAM AEM set, P < .001. Atrial tachycardia was the most common individual arrhythmia

Discussion

There are several important findings in our study. (1) The CAM recordings identified more episodes of atrial tachycardia, atrial flutter, and nonsustained VT compared to the Zio-XT monitor. (2) The CAM ECGs were ranked higher in clarity compared to the Zio-XT, allowing physician reviewers more confidence in making a specific rhythm diagnosis. (3) Both monitors were generally easy to apply and remove, and most patients had a good experience with both. (4) Differences in specific arrhythmias

Conclusions

This study demonstrates that differences in specific rhythm diagnosis and ECG clarity may exist between commercially available patch ambulatory ECG monitors. In this study, we found higher rhythm specificity with a CAM AEM. Further comparative studies should be performed.

For a more detailed description of the methods, results, and for more ECG examples from this clinical study, please refer to the electronic supplement accompanying this manuscript.

The following are the supplementary data

References (12)

There are more references available in the full text version of this article.

Cited by (19)

  • Remote and wearable ECG devices with diagnostic abilities in adults: A state-of-the-science scoping review

    2022, Heart Rhythm
    Citation Excerpt :

    The signal quality of the CAM patch was shown to be comparable to that of a Holter monitor based on reported high correlation coefficients between the 2 systems.22 In another study, the signal clarity of the CAM patch was significantly improved compared to the Zio-XT patch as indicated by the physicians’ degree of certainty for deciding on a diagnosis.26 Thus, such nonstandard positioning might compensate for the absence of multiple ECG leads.

  • Continuous ECG monitoring versus mobile telemetry: A comparison of arrhythmia diagnostics in human- versus algorithmic-dependent systems

    2021, Heart Rhythm O2
    Citation Excerpt :

    The relative merits of ECG rhythm diagnostic tools have rarely been the subject of clinical investigation. The few available studies4,5,8 have shown significantly better results with continuous LT-ECG monitoring using human oversight. Prior studies of commercial algorithms have demonstrated frequent underdiagnosis9 as well as overdiagnosis10 of AF and AFL, with resultant inappropriate treatment, including antiarrhythmic therapies and anticoagulation, or unnecessary additional testing in 24% of patients.10

  • Evaluation of a novel ambulatory electrocardiogram monitor (the Carnation Ambulatory Monitor) for use in horses

    2021, Journal of Veterinary Cardiology
    Citation Excerpt :

    ‘Wearable’ devices are comfortable and easy-to-use, can record continuous ECG data sets rather than continually re-recording a data loop and highlight patient determined events. Several studies have shown the advantage of ECG patches compared with the standard Holter because of the longer duration of recording without loss in diagnostic capabilities [6,19–21], The Bardy Dx CAM, placed on the human chest adjacent to the heart, is one such device that has demonstrated improved performance against the traditional Holter monitor and other comparable ECG patches [4–6]. We evaluated six different sites for placement of the CAM in phase 1 and demonstrated perhaps unsurprisingly that the positions closest to the heart gave the best quality signals.

View all citing articles on Scopus
View full text